Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992575 · ClinicalTrials.gov registry record
OCT in Retinal Vein Occlusions
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 4
- Enrollment target
NCT01992575 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 4 participants.
The verdict
NCT01992575 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Retinal blood vessel disease encompasses a wide variety of vision-threatening conditions. Of these conditions, retinal vein occlusions are the most common. Vision loss can occur as a result of macular ischemia (loss of blood flow to the macula) or macular edema (fluid build-up at the macula). OCT is an imaging technology that can perform non-contact cross-sectional imaging of retinal and choroidal tissue structures in real time. It is similar to ultrasound imaging, except that OCT measures the intensity of reflected light rather than sound waves. The purpose of this study is to see if non-invasive OCT technology can changes due to retinal vein occlusions as well as the more invasive fluorescein angiography, which requires an injection of dye into the vein of an arm of a patient. The study will also compare the mapping of blood vessels (angiography) and loss of blood flow (ischemia) by fluorescein angiography and OCT. These studies will be evaluated to see how they relate to vision loss.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-01 |
| Est. Completion | 2018-08-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01992575
The ClinicalTrials.gov registry entry for NCT01992575 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01992575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01992575 about?
NCT01992575 is a clinical study titled "OCT in Retinal Vein Occlusions". Retinal blood vessel disease encompasses a wide variety of vision-threatening conditions. Of these conditions, retinal vein occlusions are the most common. Vision loss can occur as a result of macular ischemia (loss of blood flow to the macula) or macular edema (fluid build-up at the macula). OCT i...
What is the current status of trial NCT01992575?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2014-01. Estimated completion is 2018-08-21.
Who is sponsoring clinical trial NCT01992575?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.